Aarti Drugs Limited - Laporan Laba Rugi (TTM)

Aarti Drugs Limited
IN ˙ BSE ˙ INE767A01016
₹ 349.10 ↑0.35 (0.10%)
2025-05-02
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aarti Drugs Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 20,459 21,027 21,548 21,900 21,916 22,961 24,886 25,306 26,387 26,679 27,161 27,552 27,090 26,510 25,286 24,228 23,796 23,303 23,870 24,222
Change (%) 2.77 2.48 1.64 0.07 4.77 8.38 1.69 4.27 1.11 1.80 1.44 -1.68 -2.14 -4.62 -4.18 -1.78 -2.07 2.44 1.47
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 12,797 12,932 13,319 13,978 14,460 15,416 17,022 17,348 18,205 18,639 19,102 19,059 18,755 18,178 16,970 15,912 15,754 15,215 15,614 15,568
Change (%) 1.06 2.99 4.95 3.45 6.62 10.41 1.92 4.94 2.39 2.48 -0.23 -1.59 -3.08 -6.65 -6.23 -0.99 -3.42 2.62 -0.29
% of Revenue 62.55 61.51 61.81 63.82 65.98 67.14 68.40 68.55 68.99 69.86 70.33 69.18 69.23 68.57 67.11 65.68 66.20 65.30 65.41 64.27
Gross Operating Profit 7,662 8,094 8,229 7,923 7,456 7,545 7,865 7,958 8,183 8,040 8,058 8,493 8,335 8,332 8,316 8,316 8,042 8,087 8,256 8,654
Change (%) 5.64 1.67 -3.72 -5.89 1.19 4.24 1.19 2.82 -1.75 0.23 5.40 -1.86 -0.04 -0.18 -0.00 -3.29 0.56 2.09 4.82
% of Revenue 37.45 38.50 38.19 36.18 34.02 32.86 31.60 31.45 31.01 30.14 29.67 30.82 30.77 31.43 32.89 34.32 33.80 34.70 34.59 35.73
SG&A 783 808 815 817 812 822 841 853 867 895 933 967 1,013 1,032 1,047 1,033 1,068 1,090 1,141 1,165
Change (%) 3.21 0.93 0.19 -0.62 1.31 2.20 1.44 1.70 3.21 4.26 3.60 4.79 1.84 1.52 -1.36 3.38 2.07 4.70 2.05
% of Revenue 3.83 3.84 3.78 3.73 3.70 3.58 3.38 3.37 3.29 3.35 3.44 3.51 3.74 3.89 4.14 4.26 4.49 4.68 4.78 4.81
R&D
Change (%)
% of Revenue
OpEx 17,062 17,249 17,667 18,568 19,002 20,159 22,003 22,563 23,641 24,182 24,608 24,805 24,322 23,740 22,636 21,732 21,437 20,937 21,557 21,839
Change (%) 1.10 2.42 5.10 2.34 6.08 9.15 2.55 4.78 2.29 1.76 0.80 -1.95 -2.39 -4.65 -3.99 -1.36 -2.33 2.97 1.31
% of Revenue 83.39 82.04 81.99 84.78 86.71 87.79 88.41 89.16 89.59 90.64 90.60 90.03 89.78 89.55 89.52 89.70 90.09 89.85 90.31 90.16
Operating Income 3,398 3,777 3,881 3,333 2,913 2,803 2,884 2,743 2,747 2,497 2,553 2,747 2,768 2,770 2,650 2,496 2,359 2,366 2,313 2,383
Change (%) 11.18 2.75 -14.13 -12.58 -3.79 2.89 -4.87 0.12 -9.11 2.25 7.60 0.79 0.05 -4.32 -5.80 -5.50 0.28 -2.24 3.02
% of Revenue 16.61 17.96 18.01 15.22 13.29 12.21 11.59 10.84 10.41 9.36 9.40 9.97 10.22 10.45 10.48 10.30 9.91 10.15 9.69 9.84
Interest Expense -295 -261 -230 -206 -188 -192 -207 -234 -266 -306 -333 -350 -348 -330 -335 -337 -344 -358 -359 -357
Change (%) -11.60 -11.89 -10.27 -8.70 2.13 8.02 12.63 13.69 15.06 8.92 5.13 -0.59 -5.09 1.49 0.52 2.03 4.25 0.11 -0.43
% of Revenue -1.44 -1.24 -1.07 -0.94 -0.86 -0.84 -0.83 -0.92 -1.01 -1.15 -1.23 -1.27 -1.28 -1.25 -1.33 -1.39 -1.44 -1.54 -1.50 -1.47
Net Income 2,474 2,876 2,804 2,438 2,111 2,014 2,050 1,910 1,872 1,656 1,663 1,794 1,802 1,802 1,714 1,568 1,522 1,526 1,682 1,888
Change (%) 16.27 -2.51 -13.07 -13.40 -4.61 1.83 -6.84 -2.02 -11.55 0.45 7.85 0.47 -0.01 -4.87 -8.52 -2.92 0.25 10.19 12.29
% of Revenue 12.09 13.68 13.01 11.13 9.63 8.77 8.24 7.55 7.09 6.21 6.12 6.51 6.65 6.80 6.78 6.47 6.40 6.55 7.04 7.80

Source: Capital IQ

Other Listings
IN:AARTIDRUGS ₹ 510.85
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista